AU626928B2 - Cyclosporin opthalmic compositions - Google Patents

Cyclosporin opthalmic compositions Download PDF

Info

Publication number
AU626928B2
AU626928B2 AU43715/89A AU4371589A AU626928B2 AU 626928 B2 AU626928 B2 AU 626928B2 AU 43715/89 A AU43715/89 A AU 43715/89A AU 4371589 A AU4371589 A AU 4371589A AU 626928 B2 AU626928 B2 AU 626928B2
Authority
AU
Australia
Prior art keywords
composition
eye
present
cyclosporin
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43715/89A
Other languages
English (en)
Other versions
AU4371589A (en
Inventor
Ronald Edward Peeples
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU4371589A publication Critical patent/AU4371589A/en
Application granted granted Critical
Publication of AU626928B2 publication Critical patent/AU626928B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AU43715/89A 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions Ceased AU626928B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26
US262866 1988-10-26

Publications (2)

Publication Number Publication Date
AU4371589A AU4371589A (en) 1990-05-03
AU626928B2 true AU626928B2 (en) 1992-08-13

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43715/89A Ceased AU626928B2 (en) 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions

Country Status (24)

Country Link
JP (1) JPH02164830A ( )
KR (1) KR900005973A ( )
AU (1) AU626928B2 ( )
BE (1) BE1003578A4 ( )
CA (1) CA2001502A1 ( )
CH (1) CH679210A5 ( )
DE (1) DE3935517A1 ( )
DK (1) DK531289A ( )
ES (1) ES2020032A6 ( )
FI (1) FI895064A0 ( )
FR (1) FR2638089A1 ( )
GB (1) GB2224205B ( )
GR (1) GR1000611B ( )
HU (1) HU203046B ( )
IL (1) IL92120A ( )
IT (1) IT1237824B ( )
LU (1) LU87613A1 ( )
MY (1) MY106271A ( )
NL (1) NL8902657A ( )
NO (1) NO894266L ( )
NZ (1) NZ231131A ( )
PT (1) PT92120B ( )
SE (1) SE8903583L ( )
ZA (1) ZA898140B ( )

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
DK0789580T3 (da) 1994-11-03 2002-09-09 Novartis Ag Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
EP0988046B1 (en) 1997-01-30 2004-09-15 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin a
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
KR20100067684A (ko) * 2007-11-05 2010-06-21 보오슈 앤드 롬 인코포레이팃드 약물 전달을 위한 비히클로서의 수불혼화성 물질
BRPI1011710B8 (pt) * 2009-06-05 2021-05-25 Allergan Inc composição para ser usada como uma lágrima artificial
CA2967413C (en) 2014-11-25 2023-08-15 Allergan, Inc. Ophthalmic compositions containing omega-3 oils stabilized by antioxidants
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
GB2224205A (en) 1990-05-02
GR890100690A (en) 1990-11-29
LU87613A1 (fr) 1991-05-07
MY106271A (en) 1995-04-29
DK531289A (da) 1990-04-27
CH679210A5 ( ) 1992-01-15
PT92120B (pt) 1995-06-30
DK531289D0 (da) 1989-10-25
IT8948485A0 (it) 1989-10-26
NO894266D0 (no) 1989-10-26
AU4371589A (en) 1990-05-03
HUT52394A (en) 1990-07-28
HU895444D0 (en) 1990-01-28
IL92120A0 (en) 1990-07-12
SE8903583L (sv) 1990-04-27
IT1237824B (it) 1993-06-18
ES2020032A6 (es) 1991-07-16
NO894266L (no) 1990-04-27
GB2224205B (en) 1992-04-15
SE8903583D0 (sv) 1989-10-26
NZ231131A (en) 1992-06-25
GR1000611B (el) 1992-08-31
CA2001502A1 (en) 1990-04-26
FR2638089A1 (fr) 1990-04-27
DE3935517A1 (de) 1990-05-03
KR900005973A (ko) 1990-05-07
GB8924040D0 (en) 1989-12-13
FI895064A0 (fi) 1989-10-25
NL8902657A (nl) 1990-05-16
JPH02164830A (ja) 1990-06-25
PT92120A (pt) 1990-04-30
ZA898140B (en) 1991-06-26
HU203046B (en) 1991-05-28
IL92120A (en) 1994-02-27
BE1003578A4 (fr) 1992-04-28

Similar Documents

Publication Publication Date Title
AU626928B2 (en) Cyclosporin opthalmic compositions
US5951971A (en) Ophthalmic compositions
US6579901B2 (en) Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
JP2006176499A (ja) 眼疾患治療剤
US11654140B2 (en) Treatment of ocular inflammatory diseases using laquinimod
Sears Regulation of aqueous flow by the adenylate cyclase receptor complex in the ciliary epithelium
EP2968139B1 (en) Microemulsion topical delivery platform
CZ423797A3 (cs) Topické přípravky s imunosupresivy
KR20200128407A (ko) 네비볼롤을 포함하는 약제학적 조성물
CN103977011B (zh) 含有曲伏前列素和噻吗洛尔的眼用凝胶剂及其制备方法
JPH0565221A (ja) 眼科用微小球
CN1216469A (zh) 含有二氢吡啶类化合物的眼组织末梢循环改善剂
JPH0381220A (ja) 眼病用製薬組成物
JPH08508975A (ja) 眼科薬送達ビヒクルとしてのサブミクロン乳剤
US20230181679A1 (en) Ophthalmic composition for the treatment of uveitis
Grehn et al. Thymoxamine: a miotic for intraocular use
Yanagawa et al. Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres
ZALTA et al. The effect of nitroglycerin ointment on the external ocular structures of rabbits
MXPA00006508A (en) Topical ophthalmic preparations containing immunosuppressive agents